Cytosorbents
CTSO
#9855
Rank
HK$0.32 B
Marketcap
HK$5.21
Share price
-1.47%
Change (1 day)
-25.45%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -HK$98.34 Million

According to Cytosorbents's latest financial reports the company's current earnings are HK$36.97 Million. In 2024 the company made an earning of -HK$0.18 Billion, an increase over its 2023 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$98.34 Million-44.34%
2024 -HK$0.18 Billion-22.49%
2023 -HK$0.23 Billion-13.52%
2022 -HK$0.27 Billion34.04%
2021 -HK$0.2 Billion182.17%
2020 -HK$69.69 Million-55.97%
2019 -HK$0.16 Billion14.17%
2018 -HK$0.14 Billion95.14%
2017 -HK$71.04 Million-22.32%
2016 -HK$91.45 Million39.1%
2015 -HK$65.75 Million-12.89%
2014 -HK$75.47 Million89%
2013 -HK$39.93 Million26.65%
2012 -HK$31.53 Million-26.02%
2011 -HK$42.62 Million-288.45%
2010 HK$22.61 M-4.17%
2009 HK$23.59 M-287.19%
2008 -HK$12.61 Million-47.12%
2007 -HK$23.85 Million41.78%
2006 -HK$16.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
HK$0.43 B-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
HK$6.20 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
HK$25.42 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA